ARCHIVES

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

This article is from The Cancer Letter archive.

Vol. 39 No. 39 | October 18, 2013

Download PDF Visit The Full Archive

Related Articles

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

Moves Forward With Approval From BSA

November 22, 2013

UICC Grant Programs Available To Support International Activities

April 16, 1976

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

The Cancer Letter Marks 25th Anniversary

December 18, 1998